Completed Research

Since 2001 the Center for Women's Health Research has been supporting principal investigators through the pre-award and post-award process. The following is a list of completed awards by category. Learn more about the history of CWHR here, as well as our current projects here.

View completed research by:

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)
  • $520,953

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013
  • $903,735

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012
  • $1,659,424

 

Efficacy & Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women w/Atrophic Vaginitis

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 12/13/2005 to 12/13/2008
  • $45,450.44

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009
  • $55,965.27

 

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010
  • $160,474.56

 

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010
  • $47,472.40

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007
  • $4,107

 

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010
  • $81,516.79

 

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011
  • $394,252

 

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008
  • $6,000

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009
  • $115,139.41

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012
  • $103,037

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013
  • $2,316,172.27

 

Time to Conceive

  • National Institute of Child Health and Human Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012
  • $406,675

 

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011
  • $15,000

 

A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharmacokinetics of GSK221149A administered orally in healthy, pregnant females with incomplicated pre-term labor between 300/7-356/7 weeks gestation

  • SmithKline Beecham Pharmaceuticals
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/25/2009 to 8/24/2012
  • $13,262.08

 

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012
  • $60,000.00

 

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012
  • $2,696.58

Pudendal Nerve Function as a Predictor of Female Sexual Function with Sacral Neuromodulation

  • American Urogynecologic Society Foundation
  • Dr. Elizabeth Geller, Obstetrics and Gynecology
  • 1/1/2010 to 3/30/2011
  • $13,000

 

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010
  • $13,145.00

 

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010
  • $9,561.59

 

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012
  • $238,992.73

 

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012
  • $35,400.00

 

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013
  • $16,000.00

 

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012
  • $100,000.00

 

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013
  • $207,387.01

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013
  • $7,294.00
No grants or clinicla trials began during 2012

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013
  • $364,349.00


Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013
  • $700,000.00


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013
  • $17,299.00

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012
  • $2,696.58

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)
  • $520,953

 

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011
  • $394,252

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012
  • $1,659,424

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008
  • $6,000

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009
  • $55,965.27

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013
  • $207,387.01

LIFE: LivSure for Fecal Incontinence. A clinical evaluation of LivSure vaginal bowel control (VBC) device for the treatment of fecal incontinence in women.

  • Pelvalon, Inc
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 3/7/2013 to 5/2014
  • $83,916.59

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012
  • $60,000.00

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012
  • $35,400.00

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010
  • $13,145.00

 

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010
  • $9,561.59

 

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012
  • $238,992.73

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013
  • $364,349.00

Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013
  • $700,000.00


Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013
  • $17,299.00

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013
  • $16,000.00

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007
  • $4,107

 

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011
  • $15,000

Time to Conceive

  • National Institute of Child Health and Human
  • Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012
  • $406,675

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013
  • $903,735

 

Efficacy & Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women w/Atrophic Vaginitis

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 12/13/2005 to 12/13/2008
  • $45,450.44

 

A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. John Thorp, Obstetrics and Gynecology
  • 10/24/2006 to 8/1/2010
  • $160,474.56

 

The Effect of Dose Titration And Dose Tapering On The Tolerability of DVS SR In Women With Vasomotor Symptoms

  • Wyeth Research
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/30/2007 to 1/28/2010
  • $47,472.40

A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...

  • GlaxoSmithKline, Inc
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/10/2007 to 8/9/2010
  • $81,516.79

 

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009
  • $115,139.41

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012
  • $103,037

 

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013
  • $2,316,172.27

A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharmacokinetics of GSK221149A administered orally in healthy, pregnant females with incomplicated pre-term labor between 300/7-356/7 weeks gestation

  • SmithKline Beecham Pharmaceuticals
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/25/2009 to 8/24/2012
  • $13,262.08

 

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013
  • $7,294.00

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012
  • $100,000.00

A Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B

  • 3M Pharmaceuticals
  • Dr. Paola Gehrig, Obstetrics and Gynecology
  • 3/24/2006 to 6/1/2009
  • $55,965.27

Develop and Implement Mobile Outreach and Intervention Protocols

  • Alvarez Associates LLC
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 12/15/2013
  • $700,000.00

ACOG - Intravaginal 5-fluorouracil for treatment of Cervical Intraepithelial Neoplasia (CIN) 2

  • American College of OB/GYN
  • Dr. Lisa Rahangdale, Obstetrics and Gynecology
  • 7/1/2010 to 7/31/2013
  • $16,000.00

Upstream maternal lifestyle factors, interleukin-6 and childhood growth from birth to age 2

  • American Diabetes Association
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 3/1/2010 to 8/31/2012
  • $238,992.73

An Investigation of Treatment of Fecal Incontinence using the TOPAS Sling

  • American Medical Systems
  • Dr. Catherine Matthews, Obstetrics and Gynecology
  • 9/14/2010 to 9/13/2013
  • $207,387.01

SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

  • Baylor College of Medicine
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 9/29/2009 to 9/28/2012
  • $60,000.00

Clinical Evaluation of the Actim PROM test

  • Binax
  • Dr. Mary Menard, Obstetrics and Gynecology
  • 3/4/2010 to 1/31/2012
  • $35,400.00

Erythromycin Gel Dosing Study Pilot Survey

  • Family Health International
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 2/1/2007 to 12/31/2007
  • $4,107

Capitation for Maternal Fetal Medicine Units Network

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2009 to 11/30/2013
  • $2,316,172.27

 

The Genomic and Proteomic Network for Preterm Birth Research Case Control Study

  • George Washington University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 2/1/2009 to 1/31/2012
  • $103,037

Understanding Barriers to Oral Health Care in Pregnancy

  • Institute of Dental and Craniofacial Research
  • Dr. Kim Boggess, Obstetrics and Gynecology
  • 9/1/2007 to 3/31/2011
  • $394,252

Roots and Shoots

  • Johns Hopkins University
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 3/1/2013 to 12/31/2013
  • $364,349.00

 

JHU Evidence-based Practice Center (EPC)Pilot Project on Identifying Research

  • Johns Hopkins University
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 10/31/2010
  • $13,145.00

Community Child Health Network, Eastern North Carolina

  • National Institute of Child Health and Human Development
  • Dr. John Thorp, Obstetrics and Gynecology
  • 8/1/2003 to 6/30/2013
  • $903,735

 

Time to Conceive

  • National Institute of Child Health and Human Development (NICHD)
  • Dr. Anne Steiner, Obstetrics and Gynecology
  • 5/15/2009 to 4/30/2012
  • $406,675

 

WRHR Career Development Center at UNC

  • National Institute of Child Health and Human Development
  • Dr. Daniel Clarke-Pearson, Obstetrics and Gynecology
  • 9/27/2005 to 3/31/2012
  • $1,659,424

 

Training in Epidemiology and Clinical Trials (TECT)

  • National Institute of Child Health and Human Development
  • Dr. David Grimes, Dr. Kim Boggess, Obstetrics and Gynecology
  • 6/27/2001 to 4/30/2016 (currently administered by OBGYN)
  • $520,953

Engaging Low income Urban Residents in Prioritizing Interventions to Address the Socio-Economic Determinants of Health

  • NIH Clinical Center
  • Dr. Joanne Garrett, Obstetrics and Gynecology
  • 9/4/2007 to 9/30/2008
  • $6,000

Evaluation of the Community Focused Eliminating Health Disparities Initiative

  • North Carolina Division of Public Health
  • Dr. Anissa Vines, Epidemeology
  • 9/1/2010 to 5/31/2012
  • $100,000.00

Chronic stress in pregnancy: Self-report, biomarkers, and birthoutcomes

  • Northwestern University
  • Dr. John Thorp, Obstetrics and Gynecology
  • 4/1/2011 to 3/31/2013
  • $7,294.00

Soluble fms-like tyrosine kinase 1 (sFlt-1), Placental Growth Factor

  • Ortho-Clinical Diagnostics
  • Dr. John Thorp, Obstetrics and Gynecology
  • 1/4/2008 to 12/31/2009
  • $115,139.41

Research on the Comparative Management of Uterine Fibroid Disease

  • Outcome Sciences, Inc.
  • Dr. Wanda Nicholson, Obstetrics and Gynecology
  • 2/1/2010 to 11/30/2010
  • $9,561.59

Treating South African Pregnant Women for Methamphetamine

  • Research Triangle Institute (RTI International)
  • Dr. Hendree Jones, UNC Horizons, Obstetrics and Gynecology
  • 4/1/2013 to 6/30/2013
  • $17,299.00

A Pilot Study of Early Postpartum Intrauterine Contraception

  • Society of Family Planning
  • Dr. Gretchen Stuart, Obstetrics and Gynecology
  • 7/2/2009 to 4/1/2011
  • $15,000

The CHIPS Trial: Control of Hypertension In Pregnancy Study

  • University of British Columbia
  • Dr. Don Armstrong, Obstetrics and Gynecology
  • 11/26/2009 to 11/25/2012
  • $2,696.58